The Fund's investment objective is to achieve long term capital growth from a portfolio primarily made up of the shares of US companies. The portfolio is likely to have a bias towards larger and medium-sized companies, although the ACD is not restricted in its choice of company by either size or industry.
Name | % Net Assets |
---|---|
Chevron Corp | 2.9% |
Merck & Co Inc | 2.6% |
Pfizer Inc | 2.5% |
Procter & Gamble Co | 2.5% |
Cisco Systems Inc | 2.5% |
Schlumberger NV | 2.5% |
Microsoft Corporation | 2.5% |
Exxon Mobil Corporation | 2.1% |
Wells Fargo & Co | 2.0% |
United Parcel Service Inc (UPS) | 2.0% |
Key | % Net Assets |
---|---|
Chevron Corp | 2.9% |
Merck & Co Inc | 2.6% |
Pfizer Inc | 2.5% |
Procter & Gamble Co | 2.5% |
Other | 89.5% |
Date | 21-Nov-2024 |
---|---|
NAV | 7,432.00p |
Currency | GBP |
Change | 89.00p |
% | 1.21% |
YTD change | 1,596.00p |
YTD % | 27.35% |
Fund Inception | 17/12/1979 |
---|---|
Fund Manager | Aris Vatis |
TER | 1.70 (29-Feb-2012) |
Minimum Investment | |
---|---|
Initial | £1000 |
Additional | £250 |
Savings | £50 |
Charges | |
---|---|
Initial | 3.50% |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | -0.08 |
You are here: research